Impact of prior paclitaxel-based chemotherapy on the outcome of salvage high-dose chemotherapy (HDCT) for relapsed germ-cell tumors (GCT): EBMT Solid Tumors Working Party (STWP)-sponsored retrospective study

被引：0

作者：

Necchi, A. ^{[1
]}

Miceli, R. ^{[2
]}

Bregni, M. ^{[3
]}

Berger, L. A. ^{[4
]}

Oechsle, K. ^{[4
]}

Schumacher, K. ^{[5
]}

Apperley, J. ^{[6
]}

Bourhis, J. H. ^{[7
]}

Laszlo, D. ^{[8
]}

Flechon, A. ^{[9
]}

Arpaci, F. ^{[10
]}

Secondino, S. ^{[11
]}

Dreger, P. ^{[12
]}

Crysandt, M. ^{[13
]}

Plueger, K. H. ^{[14
]}

Worel, N. ^{[15
]}

Krueger, W. ^{[16
]}

Ringhoffer, M. ^{[17
]}

Unal, A. ^{[18
]}

Nagler, A. ^{[19
]}

Michieli, M. ^{[20
]}

Campos, A. ^{[21
]}

Wahlin, A. ^{[22
]}

Sucak, G. ^{[23
]}

Schots, R. ^{[24
]}

Donnini, I. ^{[25
]}

Raggi, D. ^{[1
]}

Giannatempo, P. ^{[1
]}

Ifrah, N. ^{[26
]}

Badoglio, M. ^{[27
]}

Martino, M. ^{[28
]}

Pedrazzoli, P. ^{[11
]}

Lanza, F. ^{[29
]}

机构：

[1] Fdn IRCCS Ist Nazl Tumori, Med Oncol, Milan, Italy

[2] Fdn IRCCS Ist Nazl Tumori, Clin Epidemiol & Trials Org Unit, Milan, Italy

[3] Azienda Osped Busto Arsizio, Med Oncol, Busto Arsizio, Italy

[4] KMT Univ Klinikum Hamburg Eppendorf, Med Oncol, Hamburg, Germany

[5] UKGM Marburg Klin Hematol & Oncol, Med Oncol, Marburg, Germany

[6] Univ London Imperial Coll Sci Technol & Med, Hematol, London, England

[7] Gustave Roussy Inst Cancerol, Hematol BMT, Villejuif, France

[8] European Inst Oncol, Hematol BMT, Milan, Italy

[9] Ctr Leon Berard, Hematol, F-69373 Lyon, France

[10] Gulhane Mil Med Acad, GATA BMT Ctr, Ankara, Turkey

[11] Fdn IRCCS Policlin San Matteo, Med Oncol, Pavia, Italy

[12] Univ Klinikum Heidelberg, Hematol, Heidelberg, Germany

[13] Univ Hosp Aachen, Dept Oncol Hematol & SCT, Med Klin 4, Aachen, Germany

[14] EV Diakonie Krankenhaus Gemeinnitzige GmbH, Hematol, Bremen, Germany

[15] Med Univ Vienna, BMT Unit, Vienna, Austria

[16] Univ Med, Klin Innere Med Hamat Onkol C, Greifswal, Germany

[17] Klinikum Karlsruhe gGmbH, Med Klin Haematol 3, Onkol, Karlsruhe, Germany

[18] Kapadokya Cappadocia BMT Ctr, Erciyes Med Sch, Dept Hematol Oncol, Kayseri, Turkey

[19] Chaim Sheba Med Ctr, BMT Unit, IL-52621 Tel Hashomer, Israel

[20] IRCCS Aviano, CRO, Hematol, Aviano, Italy

[21] Inst Portugues Oncol Porto, BMT Unit, Oporto, Portugal

[22] Umea Univ Hosp, Hematol, Umea, Sweden

[23] Gazi Univ Med, Dept Hematol & Stem Cell Transplantat, Ankara, Turkey

[24] Univ Ziekenhuis Brussel, Div Clin Hematol, Brussels, Belgium

[25] Univ Hosp Careggi, BMT Unit, Florence, Italy

[26] CHRU Angers, BMT Unit, Angers, France

[27] EBMT, EBMT Study Off, Paris, France

[28] Azienda Osped BMM, Hematol & Bone Marrow Transplant Unit, Reggio Di Calabria, Italy

[29] Ist Ospitalieri Cremona, Hematol & Bone Marrow Transplant Unit, Cremona, Italy

来源：

BONE MARROW TRANSPLANTATION | 2015年 / 50卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O094

引用

页码：S55 / S55

页数：1

共 50 条

[31] Salvage treatment in germ cell tumors. High-dose chemotherapy and the impact of prognostic factors
Lorch, A.
Oechsle, K.
Bokemeyer, C.
Beyer, J.
UROLOGE, 2009, 48 (04): : 364 - 371
[32] Conventional-dose versus high-dose chemotherapy in relapsed or refractory male germ-cell tumors: A retrospective study in 1,594 patients
Lorch, A.
Mollevi, C.
Kramar, A.
Einhorn, L. H.
Necchi, A.
Massard, C.
DeGiorgi, U.
Flechon, A.
Margolin, K. A.
Beyer, J.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[33] First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party
G Rosti
U De Giorgi
H Wandt
B Lioure
S Leyvraz
K Kolbe
G Papiani
M Ballardini
A Kulekci
T Demirer
Bone Marrow Transplantation, 2004, 34 : 1033 - 1037
[34] First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party
Rosti, G
De Giorgi, U
Wandt, H
Lioure, B
Leyvraz, S
Kolbe, K
Papiani, G
Ballardini, M
Kulekci, A
Demirer, T
BONE MARROW TRANSPLANTATION, 2004, 34 (12) : 1033 - 1037
[35] High-dose chemotherapy (HDCT) and peripheral-blood stem cell transplant (PBSCT) in patients age 40 or older with relapsed metastatic germ-cell tumors (mGCT).
Agrawal, Vaibhav
Althouse, Sandra K.
Abonour, Rafat
Abu Zaid, Mohammad Issam
Sullivan, Cheryl K.
Hanna, Nasser H.
Einhorn, Lawrence H.
Adra, Nabil
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[36] Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant
Einhorn, Lawrence H.
Brames, Mary J.
Juliar, Beth
Williams, Stephen D.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) : 513 - 516
[37] Incidence of secondary malignancies (SM) in patients (pts) with germ cell tumors (GCT) who received high-dose chemotherapy (HDCT): A retrospective study from the European Society for Blood and Marrow Transplantation (EBMT) database.
Secondino, Simona
Necchi, Andrea
Rosti, Giovanni
Badoglio, Manuela
Raggi, Daniele
Giannatempo, Patrizia
Lanza, Francesco
Pedrazzoli, Paolo
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[38] Incidence of secondary malignancies (SM) in patients (pts) with germ cell tumors (GCT) who received high-dose chemotherapy (HDCT): A retrospective study from the European Society for Blood and Marrow Transplantation (EBMT) database.
Necchi, Andrea
Rosti, Giovanni
Badoglio, Manuela
Giannatempo, Patrizia
Secondino, Simona
Lanza, Francesco
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
[39] Standard-dose salvage chemotherapy in patients with refractory metastatic germ-cell tumors (mGCT) progressing after high-dose chemotherapy (HDCT) and peripheral-blood stem-cell transplant (PBSCT).
Agrawal, Vaibhav
Althouse, Sandra K.
Hanna, Nasser H.
Einhorn, Lawrence H.
Adra, Nabil
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[40] Prognostic value of FDG-PET in classification of residual tumors after high-dose (HD) chemotherapy (CTX) of metastatic germ-cell tumors (GCT)
Pfannenberg, AC
Dohmen, BM
Bokemeyer, C
RADIOLOGY, 1998, 209P : 169 - 169

← 1 2 3 4 5 →